- Home
- SOHU vs LXRX Comparison
SOHU vs LXRX Comparison
Compare SOHU & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- LXRX
- Stock Information
- Founded
- SOHU 1996
- LXRX 1995
- Country
- SOHU China
- LXRX United States
- Employees
- SOHU N/A
- LXRX N/A
- Industry
- SOHU EDP Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- LXRX Health Care
- Exchange
- SOHU Nasdaq
- LXRX Nasdaq
- Market Cap
- SOHU 468.1M
- LXRX 428.8M
- IPO Year
- SOHU 2000
- LXRX 2000
- Fundamental
- Price
- SOHU $15.77
- LXRX $1.09
- Analyst Decision
- SOHU Strong Buy
- LXRX Buy
- Analyst Count
- SOHU 1
- LXRX 5
- Target Price
- SOHU $20.00
- LXRX $3.23
- AVG Volume (30 Days)
- SOHU 71.7K
- LXRX 1.6M
- Earning Date
- SOHU 11-11-2025
- LXRX 11-11-2025
- Dividend Yield
- SOHU N/A
- LXRX N/A
- EPS Growth
- SOHU N/A
- LXRX N/A
- EPS
- SOHU 4.10
- LXRX N/A
- Revenue
- SOHU $548,588,000.00
- LXRX $58,432,000.00
- Revenue This Year
- SOHU N/A
- LXRX N/A
- Revenue Next Year
- SOHU $2.29
- LXRX N/A
- P/E Ratio
- SOHU $3.82
- LXRX N/A
- Revenue Growth
- SOHU N/A
- LXRX 1504.83
- 52 Week Low
- SOHU $7.79
- LXRX $0.28
- 52 Week High
- SOHU $17.24
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- SOHU 52.34
- LXRX 47.78
- Support Level
- SOHU $15.49
- LXRX $1.03
- Resistance Level
- SOHU $16.21
- LXRX $1.19
- Average True Range (ATR)
- SOHU 0.49
- LXRX 0.06
- MACD
- SOHU -0.08
- LXRX -0.00
- Stochastic Oscillator
- SOHU 38.74
- LXRX 35.29
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.